INFORMATION FOR PATIENTS TAKING SYMPAZAN® (CLOBAZAM) ORAL FILM

May 22, 2020

The SYMPAZAN® Savings Program offers additional savings for eligible, commercially-insured patients.

Beginning immediately through September 30, 2020, Aquestive will be offering a $0 copay for all prescriptions and refills of SYMPAZAN® for
eligible, commercially-insured non-government patients. There is no maximum monthly or annual limit on the amount patients may receive to
meet copays and deductibles.

Recall – Vigabatrin for Oral Solution USP

by Naka King | Dec 12, 2023

TOPIC: Vigabatrin for Oral Solution USP, 500 mg by InvaGen Pharmaceuticals: Recall - Due to Leaking Sachets AUDIENCE: Patient, Health Professional, Pharmacy, Pediatric, Neurology ISSUE: InvaGen Pharmaceuticals is recalling one lot, NB301030, of Vigabatrin for Oral...

INFORMATION FOR PATIENTS TAKING SYMPAZAN® (CLOBAZAM) ORAL FILM

Related Posts

Recall – Vigabatrin for Oral Solution USP